Antineoplastic agents - dimefluron and oracin - did not produce any significant signs of cardiotoxicity during repeated (10 weeks) parenteral administration in doses used (dimefluron - cumulative doses 120 and 240 mg/kg i.v.; oracin 50 and 100 mg/kg i.v.